p53-Mdm2 interaction targeted therapy by Nutlin-3 on nasopharyngeal carcinoma cells / Voon Yee Lin
Nutlin-3, a small-molecule inhibitor of p53-Mdm2 interaction, is known to be effective against cancers expressing wild-type (wt) p53. p53 mutations are rare in nasopharyngeal carcinoma (NPC), and hence targeting the disruption of p53-Mdm2 interaction to reactivate p53 may offer a promising therap...
Saved in:
Main Author: | Voon, Yee Lin |
---|---|
Format: | Thesis |
Published: |
2016
|
Subjects: | |
Online Access: | http://studentsrepo.um.edu.my/7090/4/yee_lin.pdf http://studentsrepo.um.edu.my/7090/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epstein-Barr Virus as a promising immunotherapeutic target for nasopharyngeal carcinoma treatment
by: Teow, Sin Yeang *, et al.
Published: (2017) -
Chromosome fragility in nasopharyngeal carcinoma (NPC)
by: Yee, Peter Han Chung
Published: (2007) -
Molecular genetic studies of nasopharyngeal carcinoma : mutation analysis and susceptibility gene isolation
by: Toh, Alan Kie Leong.
Published: (2007) -
CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma
by: Hoe, Susan Ling Ling, et al.
Published: (2017) -
Genetic susceptibility factors in familial nasopharyngeal carcinoma
by: Kaderi, Mohd Arifin, et al.
Published: (2016)